ACIP Presentation Slides: February 24-25, 2021 Meeting
On This Page
Note: These files are not yet 508
We will add links to presentations as they are available.
February 24, 2021
Welcome & Introductions
- Welcome and Introductions
Dr. J Romero
Dr. A Cohn
Rabies Vaccines
- Introduction pdf icon[8 pages]
Dr. S Frey - Rabies pre-exposure prophylaxis: summary of background information pdf icon[21 pages]
Dr. A Rao - Rabies pre-exposure prophylaxis: summary of Evidence to Recommendations pdf icon[35 pages]
Dr. A Rao - Approach to rabies post-exposure prophylaxis pdf icon[25 pages]
Dr. A Rao - Work group interpretations of data about rabies immune globulin and next steps for the WG pdf icon[20 pages]
Dr. A Rao - Rabies Vaccines
Dr. A Rao
Dengue Vaccine
- Introduction pdf icon[8 pages]
Dr. K Poehling - Results of dengue test independent evaluation pdf icon[25 pages]
Dr. F Medina - Workgroup interpretation pdf icon[7 pages]
Dr. G Paz-Bailey
Tick-borne Encephalitis (TBE) Vaccine
- Introduction pdf icon[6 pages]
Dr. K Poehling - TBE epidemiology in TBE endemic areas pdf icon[26 pages]
Dr. S Hills - TBE among US civilian travelers and laboratory workers pdf icon[17 pages]
Dr. E Staples - TBE among military personnel and dependents pdf icon[22 pages]
Dr. B McClenathan - Summary of risks of TBE for U.S. travelers and laboratory workers and next steps pdf icon[11 pages]
Dr. S Hills
Ebola Vaccine
- Introduction pdf icon[10 pages]
Dr. S Frey - Background on state designated Ebola Treatment Centers (ETC) pdf icon[23 pages]
Dr. A Joyce - Laboratory Response Network (LRN) facilities and survey results pdf icon[22 pages]
Dr. A Joyce - Review of preliminary workgroup discussions pdf icon[19 pages]
Dr. C Cossaboom
Hepatitis Vaccine
- Introduction pdf icon[5 pages]
Dr. S Frey
- Background pdf icon[25 pages]
Dr. M Weng - Economic analysis pdf icon[36 pages]
Dr. E Hall
February 25, 2021
Welcome & Introductions
- Welcome and Introductions
Dr. J Romero
Dr. A Cohn
Pneumococcal Vaccines
- Introduction pdf icon[10 pages]
Dr. K Poehling - Current epidemiology of pneumoccocal disease and pneumococcal vaccine coverage in US adults pdf icon[33 pages]
Dr. R Gierke - PCV20 Phase 2/3 study results in adults pdf icon[16 pages]
Dr. W Watson - PCV15 Phase 2/3 study results in adults, including adults with underlying conditions pdf icon[38 pages]
Dr. U Buchwald - Considerations for PCV15 and PCV 20 use in adults pdf icon[43 pages]
Dr. M Kobayashi
Zoster Vaccine
- Introduction pdf icon[8 pages]
Dr. G Lee - Risk of Guillain-Barré syndrome (GBS) following recombinant zoster vaccine (RZV) pdf icon[15 pages]
Dr. R Forshee - RZV risk-benefit analysis pdf icon[21 pages]
Dr. L Prosser - Work group interpretation pdf icon[7 pages]
Dr. T Anderson - Introduction of the Evidence to Recommendations Framework for use of RZV in immunocompromised adults pdf icon[19 pages]
Dr. T Anderson
Influenza Vaccines
- Introduction pdf icon[5 pages]
Dr. K Talbot
- Influenza surveillance update and work group considerations pdf icon[26 pages]
Dr. L Grohskopf
Cholera Vaccine
- Introduction pdf icon[5 pages]
Dr. P Sanchez - Introduction to cholera and cholera vaccines pdf icon[47 pages]
Dr. J Collins - Vaxchora safety and immunogenicity data pdf icon[24 pages]
Dr. J McCarty - Work group plans pdf icon[3 pages]
Dr. J Collins
Orthopoxviruses Vaccines
Page last reviewed: June 24, 2021
Content source: National Center for Immunization and Respiratory Diseases